This 2 arm randomized clinical trial will assess the impact of Dienogest and N-Acetyl Cysteine on volume reduction of uterine leiomyoma
Group A women will receive Dienogest orally 2mg pills daily for 3 months .20 cases Group B women will receive NAC orally at a dose of 600 mg/day for 3 months ,20 cases
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Enrollment
40
Clinical trial
Clinical trial
Ainshams University
Cairo, Egypt
leiomyoma size reduction
vertical x horizontal diameter in mm by transvaginal U/S
Time frame: 3 months
Dysmenorrhea
according to the visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. The scale is composed of 0 (no pain at all) to 10 (worst imaginable pain)
Time frame: 3 Monthes
heavy menstrual bleeding
assess by PBAC score
Time frame: 3 months
blood loss
by hemoglobin level
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.